Compound Detail
CHEMBL517140
GSK189254 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL517140 |
| Name | GSK189254 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | WROHEWWOCPRMIA-UHFFFAOYSA-N |
2
Targets
10
Activities
2
Assay Types
5
PK Parameters
20
Publications
2
Known Names
1
Indications
1
Mechanisms
Molecular Properties
351.4
MW (Da)
3.19
ALogP
4
HBA
1
HBD
54.5
PSA (Ų)
0.92
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Histamine H3 receptor antagonist | ANTAGONIST | Histamine H3 receptor | ✓ | ✓ |
Indications
Narcolepsy
Activity Summary
Ki 9 meas. best 9.92
IC50 1 meas. best 9.26
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histamine H3 receptor CHEMBL264 | Ki | 9.92 | 9.7667 | 0.1 | 6 |
| Histamine H3 receptor CHEMBL264 | IC50 | 9.26 | 9.26 | 0.6 | 1 |
| Histamine H3 receptor CHEMBL4124 | Ki | 9.2 | 8.9833 | 0.6 | 3 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 2596.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 0.5 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.5 | mL.min-1.g-1 | Rattus norvegicus |
| Cmax | 1237.73 | nM | Rattus norvegicus |
| F | 51.0 | % | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine